086820 — Bio Solution Co Balance Sheet
0.000.00%
- KR₩226bn
- KR₩240bn
- KR₩13bn
Annual balance sheet for Bio Solution Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 36,204 | 83,084 | 72,800 | 37,710 | 14,350 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3,057 | 2,602 | 4,659 | 4,780 | 5,061 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 40,687 | 87,055 | 79,159 | 44,239 | 20,983 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 5,230 | 3,945 | 8,448 | 6,914 | 6,450 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 49,798 | 94,404 | 91,731 | 92,347 | 67,464 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,021 | 48,861 | 45,853 | 47,055 | 33,384 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 3,134 | 49,391 | 47,955 | 50,218 | 36,207 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Total Equity | 46,664 | 45,013 | 43,775 | 42,130 | 31,257 |
Total Liabilities & Shareholders' Equity | 49,798 | 94,404 | 91,731 | 92,347 | 67,464 |
Total Common Shares Outstanding |